A
Kumaka Industries
ASHOKORG
Kumaka Industries
Commodities Chemicals & Petrochemicals
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Debtor days have improved from 154 to 17.8 days.
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -1.05% over last 3 years.
Growth Rate
Revenue Growth
91% lower than
3Y
Net Income Growth
-267% lower than
3Y
Quarterly Results
| Particulars | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.02 | 0.02 | 0.06 | 0.03 | 0.03 | 0.03 | 0.12 | 0.05 | 0.12 | 0.14 | 0.09 | 0.09 |
| Expenses | 0.08 | 0.22 | 0.16 | 0.1 | 0.07 | 0.07 | 0.1 | 0.08 | 0.11 | 0.19 | 0.13 | 0.27 | 0.1 |
| Operating Profit | -0.06 | -0.2 | -0.14 | -0.04 | -0.04 | -0.04 | -0.07 | 0.04 | -0.06 | -0.07 | 0.01 | -0.18 | -0.01 |
| OPM % | -300% | -1000% | -700% | -66.67% | -133.33% | -133.33% | -233.33% | 33.33% | -120% | -58.33% | 7.14% | -200% | -11.11% |
| Other Income | 0.01 | -0.07 | -0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.14 | 0.01 | 0.01 | -0.37 | 0.02 | 0.16 |
| Interest | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| PBT | -0.05 | -0.3 | -0.18 | -0.01 | -0.02 | -0.03 | -0.06 | 0.17 | -0.06 | -0.07 | -0.37 | -0.17 | 0.15 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.05 | -0.3 | -0.19 | -0.01 | -0.02 | -0.03 | -0.06 | 0.17 | -0.05 | -0.07 | -0.37 | -0.16 | 0.15 |
Profit & Loss
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.2 | 0.01 | 0.02 | 0.12 | 0.19 | 0.41 | 0.44 |
| Expenses | 7.13 | 2.42 | 0.41 | 2.7 | 1.31 | 0.98 | 0.97 | 0.43 | 0.72 | 0.55 | 0.31 | 0.7 | 0.69 |
| Operating Profit | -7.13 | -2.42 | -0.41 | -2.7 | -1.31 | -0.93 | -0.77 | -0.42 | -0.7 | -0.43 | -0.12 | -0.29 | -0.25 |
| OPM % | — | — | — | — | — | -1860% | -385% | -4200% | -3500% | -358.33% | -63.16% | -70.73% | -56.82% |
| Other Income | 18.04 | -2.23 | -24.57 | 6.12 | 5.78 | 1.07 | 0.25 | 0.1 | -0.96 | -0.08 | 0.18 | -0.34 | -0.18 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0 |
| Depreciation | 5.63 | 5.24 | 0.07 | 0.07 | 0.08 | 0.13 | 0.14 | 0.14 | 0.04 | 0.01 | 0.01 | 0.03 | 0.03 |
| PBT | 5.28 | -9.89 | -25.05 | 3.35 | 4.39 | 0.01 | -0.66 | -0.46 | -1.73 | -0.55 | 0.05 | -0.66 | -0.46 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | 5.28 | -9.89 | -25.05 | 3.35 | 4.39 | 0.01 | -0.67 | -0.46 | -1.73 | -0.54 | 0.05 | -0.66 | -0.45 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.08 |
| Reserves | -160 | -131 | 20.36 | 23.71 | 26.74 | 10.39 | 9.73 | 6.97 | 7.23 | 6.68 | 6.73 | 6.09 |
| Borrowings | 239 | 181 | 1.81 | 0.16 | 0.03 | 0.99 | 1.5 | 0 | 0 | 0 | 0 | 0.06 |
| Other Liabilities | 5.77 | 15.56 | 8.65 | 7.73 | 3.77 | 2.39 | 2.36 | 3.78 | 3.84 | 5.7 | 5.84 | 0.32 |
| Total Liabilities | 96.5 | 78.09 | 42.91 | 43.69 | 42.63 | 25.86 | 25.68 | 22.84 | 23.16 | 24.47 | 24.66 | 18.55 |
| Fixed Assets | 54.21 | 38.19 | 4.38 | 2.84 | 2.69 | 2.63 | 2.49 | 12.4 | 13.76 | 14.58 | 14.94 | 14.92 |
| CWIP | 1.64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.44 | 0.71 | 0 | 2.36 | 0.09 | 3.92 | 3.92 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 40.21 | 39.19 | 38.53 | 38.49 | 39.85 | 19.31 | 19.27 | 10.43 | 9.39 | 9.88 | 9.71 | 3.62 |
| Total Assets | 96.5 | 78.09 | 42.91 | 43.69 | 42.63 | 25.86 | 25.68 | 22.84 | 23.16 | 24.47 | 24.66 | 18.55 |
Cash Flow
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -9.02 | -5.3 | -33.18 | 2.97 | -0.69 | 19.04 | -0.62 | -6.69 | -0.87 | 1.12 | -0.02 | 1.52 |
| Investing | 4.85 | 11.13 | 34.5 | -0.85 | 5.04 | -3.78 | 0 | 6.81 | 0.78 | -1.12 | 0 | -1.51 |
| Financing | 4.21 | -5.88 | -1.69 | -1.99 | -0.14 | -15.4 | 0.5 | 0 | 0 | -0.03 | 0 | 0 |
| Net Cash Flow | 0.04 | -0.05 | -0.37 | 0.13 | 4.21 | -0.14 | -0.11 | 0.12 | -0.09 | -0.04 | -0.02 | 0.01 |
| Free Cash Flow | -9.01 | 5.83 | 0.62 | 4.51 | 2.15 | 19.1 | -0.62 | 1.01 | -0.79 | 0.23 | -0.39 | 1.51 |
| CFO/OP | 127 | 219 | 8,093 | -110 | 53 | -2,047 | 81 | 1,586 | 124 | -267 | 17 | -541 |
Ratios
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | — | — | — | — | 1,971 | 475 | 9,125 | 0 | 213 | 231 | 17.8 |
| Inventory Days | — | 34.22 | 0 | — | — | 456 | 21.47 | 365 | 0 | — | 0 | 0 |
| Days Payable | — | 81.74 | — | — | — | 821 | 193 | 0 | — | — | — | — |
| Cash Conversion Cycle | — | — | — | — | — | 1,606 | 303 | 9,490 | 0 | 213 | 231 | 17.8 |
| Working Capital Days | — | — | — | — | — | -22,192 | -6,479 | 1,48,555 | 67,890 | 5,962 | 3,784 | -187 |
| ROCE % | 2.91% | -9.71% | 1.34% | -3.79% | 4.6% | 0.03% | -2.82% | -0.52% | -3.65% | -1.89% | 0.27% | -1.4% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Kumaka Industries insights
38 extracted metrics + investor summaries across FY10–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2 Mar - Tata Technologies partners with WITTENSTEIN to integrate SAFE RTOS into SDV software stack, announced March 2, 2026. 2 Mar - Tata Technologies partners with WITTENSTEIN to integrate SAFE RTOS into SDV software stack, announced March 2, 2026.
2
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
28 Feb - Of allotment of 177622 equity shares under Tata Technologies Limited Share Based Long Term Incentive Scheme 2022 28 Feb - Of allotment of 177622 equity shares under Tata Technologies Limited Share Based Long Term Incentive Scheme 2022
4
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
27 Feb - Investor meetings on Feb 27, 2026 with multiple mutual funds; no UPSI shared. 27 Feb - Investor meetings on Feb 27, 2026 with multiple mutual funds; no UPSI shared.
5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16h - Investor meetings held Feb 26, 2026 with multiple asset managers and funds; no UPSI shared. 16h - Investor meetings held Feb 26, 2026 with multiple asset managers and funds; no UPSI shared.
Frequently Asked Questions about Kumaka Industries
What does Kumaka Industries Ltd do?
Kumaka Industries Ltd. is engaged in manufacturing pharmaceutical products. The company offers corticosteroids and salts. Kumaka Industries Ltd.
Which sector does Kumaka Industries Ltd belong to?
Kumaka Industries Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
Company Information
Kumaka Industries Ltd. is engaged in manufacturing pharmaceutical products. The company offers corticosteroids and salts. Kumaka Industries Ltd.
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ASHOKORG.md for Kumaka Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.